Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong · Delayed Price · Currency is HKD 0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 177.82 | 177.82 | 180.59 | 190.93 | 213.85 | 225.24 |
Revenue Growth | -0.33% | -1.54% | -5.42% | -10.71% | -5.06% | 1.28% |
Gross Profit Gross Profit Growth | 87.88 | 87.88 | 89.78 | 89.64 | 120.76 | 142.21 |
Operating Income Operating Income Growth | -49.26 | -49.26 | -33.55 | -56.23 | -7.72 | 35.49 |
Net Income Net Income Growth | -46.41 | -46.41 | -34.29 | -75.79 | -3.19 | 13.49 |
Earnings Per Share EPS Growth | -0.09 | -0.09 | -0.06 | -0.14 | -0.01 | 0.03 |
EPS Growth | - | - | - | - | - | -63.61% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Ophthalmic Service Income Ophthalmic Service Income Growth | 166.99 | 166.99 | 171.04 | 179.07 | 206.52 | 217.89 |
Sales of Prescriptions Sales of Prescriptions Growth | 8.23 | 8.23 | 7.02 | 7.69 | 7.33 | 7.35 |
Sales of Vision Products Sales of Vision Products Growth | 2.59 | 2.59 | 2.53 | 4.17 | - | - |
Total Total Growth | 177.82 | 177.82 | 180.59 | 190.93 | 213.85 | 225.24 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 93.17 | 93.17 | 132.57 | 141.43 | 207.5 | 241.27 |
Total Debt Total Debt Growth | 28.49 | 28.49 | 9.91 | 25.41 | 47.26 | 20.18 |
Net Cash (Debt) Net Cash Growth | 64.68 | 64.68 | 122.67 | 116.02 | 160.24 | 221.1 |
Net Cash Growth | -21.11% | -47.27% | 5.73% | -27.59% | -27.53% | 317.92% |
Net Cash Per Share Net Cash Per Share Growth | 0.12 | 0.12 | 0.23 | 0.22 | 0.31 | 0.57 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -28.38 | -28.38 | 17.88 | -15.58 | 16.22 | 27.55 |
Capital Expenditures CapEx Growth | -0.67 | -0.67 | -7.53 | -32.81 | -30.2 | -0.21 |
Free Cash Flow Free Cash Flow Growth | -29.05 | -29.05 | 10.34 | -48.39 | -13.98 | 27.35 |
Free Cash Flow Growth | - | - | - | - | - | -56.01% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 49.42% | 49.42% | 49.72% | 46.95% | 56.47% | 63.14% |
Operating Margin | -27.70% | -27.70% | -18.57% | -29.45% | -3.61% | 15.75% |
Pretax Margin | -27.03% | -27.03% | -20.44% | -42.89% | -1.36% | 8.46% |
Profit Margin | -26.10% | -26.10% | -18.99% | -39.70% | -1.49% | 5.99% |
FCF Margin | -16.34% | -16.34% | 5.73% | -25.35% | -6.54% | 12.14% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | 47.23 |
P/FCF Ratio | - | - | 19.69 | - | - | 23.30 |
PS Ratio | 1.06 | 1.07 | 1.13 | 1.88 | 2.32 | 2.83 |